European Archives - Page 229 of 1108 - European Medical Journal

European Commission gives green light to Roche’s PNH treatment

Roche has secured European Commission approval for its drug crovalimab, marking a significant advancement in the treatment of PNH.

Understanding Developmental and Epileptic Encephalopathies

Developmental and epileptic encephalopathy (DEE) refers to a collection of rare and severe epilepsies that feature both seizures and…

EMJ Neurology 12 [Supplement 3] 2024

This article summarises a fascinating interview with neurologist Antonietta Coppola, University of Naples Federico II, Italy, in which she…

joint pain from gout

Light Alcohol Cuts Gout Risk in Women, But Increases in Men

A RECENT study has found a link between alcohol consumption and the risk of developing gout.

Liver Stiffness Identified as an Indicator of Hepatitis C Risk

Recent studies suggest liver stiffness as the primary indicator for assessing long-term risk after Hepatitis C virus treatment

Novel Non-invasive Model to Detect Varices in Hepatocellular Carcinoma

A new model combining clinical and imaging data effectively predicts the absence of high-risk varices in patients with unresectable hepatocellular carcinoma

Lecanemab Binds Amyloid Plaques in People with Down Syndrome

A new study reveals that an Alzheimer’s drug, binds effectively to amyloid plaques in people with Down syndrome but raises safety concerns due to its interaction with brain blood vessels.

Genetic Switches Drive Mutation in Colorectal Cancer

A new study has uncovered a mechanism that drives the evolution of mismatch repair deficient colorectal cancer, a type of cancer known for its high mutation rates.

Untreated Late-Life Hypertension Increases Alzheimer's Disease Risk

Recent research has shown that antihypertensive medications may reduce the risk of all-cause dementia by 13% and Alzheimer’s disease.

Bavarian Nordic to manufacture 440,000 doses of mpox vaccine

Bavarian Nordic has entered into a significant agreement to manufacture 440,000 additional doses of its vaccine in response to the escalating mpox outbreak.